1Hochhaus A, Reiter A, Reiter A, Saussele S, et al. Molecular heterogeneity in compiete cytogenetic responders after interferon - a therapy for chronic myelogenous leukemia:low levels of minimal residual disease are associated with continuing remission. Blood,2000,95:62-66.
3Gilleece MH. D. Donor lymphoctye infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemia. Leuk Lymphoma, 2003,4:23 -28.
4Petersdoff E, Anasetti C, Servida P, et al. Effect of HLA matching on outcome of related and unrelated donor transplantation therapy for chronic myelogenous leukemia. Hemateol, Oncol Clin North Am, 1998,12 : 107-121.
5Gilleece MH, Dazzi F. Donor lymphocyte infusions for patients who relapse after allongeic stem cell transplantation for chronic myeloid leukemia. Leuk Lymphoma,2003,4 : 23 -28.
